Kymera Therapeutics Cash Flow Statement 2019-2024 | KYMR

Fifteen years of historical annual cash flow statements for Kymera Therapeutics (KYMR).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-146.96$-154.81$-100.22$-45.59$-41.25
$-1.66$3.87$8.20$3.33$0.83
$43.12$35.48$24.99$5.52$1.64
$41.45$39.35$33.19$8.86$2.46
$-15.00$0$0.58$-0.58$0.15
$0$0$0$0$0
$2.04$0.25$0.05$0.99$0.90
$12.46$-42.40$-75.15$119$53.39
$2.68$-37.62$-61.92$125$56.69
$-102.83$-153.09$-128.95$88.13$17.91
$-34.48$-2.84$-1.60$-9.10$-0.53
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$174$23.36$-98.24$-413.49$-15.95
$174$23.36$-98.24$-413.49$-15.95
$0$0$0$0$0
$140$20.52$-99.84$-422.59$-16.49
$-0.08$-1.13$-0.85$-0.55$-0.37
$0$0$0$0$0
$-0.08$-1.13$-0.85$-0.55$-0.37
$2.86$153$251$183$0.07
$2.86$153$251$276$35.28
$0$0$0$0$0
$1.41$1.15$0.39$13.53$0
$4.19$153$250$289$34.91
$41.25$20.43$21.50$-45.20$36.33
$43.12$35.48$24.97$5.19$1.20
$0$0$0$0$0